Research
June 3, 2021
UAMS Donald W. Reynolds Institute on Aging Receives $1.9 Million Grant to Research Link Between Blood Sugar, Alzheimer’s Disease
The Donald W. Reynolds Institute on Aging at the University of Arkansas for Medical Sciences (UAMS) has been awarded a five-year, $1.9 million grant from the National Institute on Aging, a division of the National Institutes of Health.
May 11, 2021
UAMS Cancer Researcher Hong-yu Li, Ph.D., Awarded $1.27 Million Grant
LITTLE ROCK — Hong-yu Li, Ph.D., a researcher with the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), recently received a five-year, $1,265,834 grant from the National Institutes of Health and the National Cancer Institute to work toward developing treatment options for acute myeloid leukemia patients. Li, a professor…
May 10, 2021
NIH Grant Supporting UAMS Study of Drugs to Improve Long-term Kidney Transplant Outcomes
LITTLE ROCK — A National Institutes of Health (NIH) grant will allow UAMS researcher Nirmala Parajuli, DVM, Ph.D., to study a novel way to improve the long-term outcomes of patients who receive kidneys from deceased donors. Parajuli, an assistant professor in the College of Medicine Department of Pharmacology and Toxicology, will use the five-year $2.46…
May 7, 2021
UAMS Physician’s New Skills and Lucky Timing Save Vilonia Baby from Deadly, Disabling Disease
Oliver Hurst owes his life to a luckily timed move across the country. His father and mother, who was then three months pregnant with Oliver, arrived in Vilonia from California in March 2020. At the time, UAMS’ Kapil Arya, M.D., was developing strategies as a UAMS Translational Research Institute Implementation Science Scholar to establish statewide…
May 5, 2021
Latest Virtual Showcase of Medical Discoveries Focuses on Cardiovascular Research
Efforts to better understand heart problems and improve methods of detection and outcomes were the focus of the University of Arkansas for Medical Sciences (UAMS) most recent Showcase of Medical Discoveries, this time focused on cardiovascular research. The virtual event, held April 21, was the 30th showcase sponsored by the UAMS Division of Research and…
May 3, 2021
American Heart Association’s Sweethearts Learn About Heart From UAMS Experts
About 35 high school sophomores who are part of the American Heart Association’s Sweetheart Program got a close look into the inner workings of the heart in a virtual session April 26 at the University of Arkansas for Medical Sciences (UAMS). The Sweethearts are high school sophomores who, over several months, learn about heart-healthy lifestyles…
April 26, 2021
UAMS Studies Highlight Endocrine Disorders that Put Children at Higher Risk for COVID-19 Complications, Death
COVID-19 infections put children at much higher risk for complications and death if they have either poorly controlled diabetes or adrenal insufficiency, according to two studies by researchers at the University of Arkansas for Medical Sciences (UAMS). One study found that children with poorly controlled Type 1 diabetes have a much higher risk of COVID-19-related…
April 22, 2021
UAMS Researcher Awarded $1.7 Million NIH Grant to Study Deadly Pathogen that Causes Severe Pneumonia
LITTLE ROCK — The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded a five-year $1.7 million grant to a University of Arkansas for Medical Sciences (UAMS) researcher studying the pathogenesis of pulmonary infection. The UAMS laboratory run by Roger Pechous, Ph.D., an assistant professor in the College…
April 20, 2021
UAMS Cancer Researcher Receives $1.1 Million as Part of NIH Grant at University of Arkansas, Fayetteville
A National Institutes of Health (NIH) grant will allow UAMS researcher Isabelle Racine Miousse, Ph.D., to ramp up her study of a nutrient that may have a role in the effectiveness of immunotherapy for cancer patients. Miousse will receive $220,000 per year for up to five years as one of four project leaders at the…
April 12, 2021
Cancer DNA Blood Tests Validated By International Research Team
LITTLE ROCK — An international team today reports the findings of an independent assessment of five commercially-available assays for tumor DNA sequencing – a fast, cheap and less invasive method to diagnose and monitor cancer.
Previous page Next page